DiaMedica Therapeutics (DMAC) Stock Chart & Stock Price History $5.19 +0.61 (+13.28%) As of 01:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics Stock Price Performance The DiaMedica Therapeutics (DMAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 45.75%, with a year-to-date return of -5.25%. In the past month, the stock has increased 41.74%, reflecting recent market activity. As of the latest close, DiaMedica Therapeutics traded at $4.58 with a market cap of $236.74 million and volume of 138,203 shares. Five years ago, the stock traded at $5.40, representing a 4.72% decrease over that period. At the time, it had a market cap of $77.77 million and a volume of 73,800 shares. Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.74%1 Month Performance+41.74%3 Month Performance+34.33%Year-To-Date Performance-5.25%1 Year Performance+45.75%5 Year Performance-4.72% DMAC Stock Chart for Tuesday, August, 12, 2025 DMAC Chart by TradingView DiaMedica Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$4.67$4.58-1.93%$4.71$4.39138,203 shs$236.74 million08/08/2025$4.82$4.67-3.11%$4.94$4.41390,287 shs$241.39 million08/07/2025$4.72$4.82+2.12%$5.09$4.77559,250 shs$249.14 million08/06/2025$4.49$4.72+5.12%$4.78$4.50291,512 shs$243.98 million08/05/2025$4.36$4.49+2.98%$4.64$4.31350,920 shs$192.53 million08/04/2025$4.12$4.36+5.83%$4.47$4.15242,805 shs$186.97 million08/01/2025$4.22$4.12-2.37%$4.17$4.01203,997 shs$176.67 million07/31/2025$4.45$4.22-5.17%$4.61$4.20348,394 shs$180.97 million07/30/2025$4.59$4.45-3.05%$4.70$4.39382,197 shs$190.82 million07/29/2025$5.06$4.59-9.29%$5.15$4.59718,877 shs$196.82 million Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$5.05$5.06+0.20%$5.60$5.00610,334 shs$216.99 million07/25/2025$4.88$5.05+3.48%$5.25$4.81301,626 shs$216.56 million07/24/2025$5.15$4.88-5.24%$5.16$4.88322,489 shs$209.25 million07/23/2025$4.60$5.15+11.96%$5.25$4.54626,212 shs$220.83 million07/22/2025$4.54$4.60+1.32%$4.63$4.35314,976 shs$197.26 million07/21/2025$4.18$4.54+8.61%$5.04$4.15831,248 shs$194.68 million07/18/2025$3.93$4.18+6.36%$4.36$3.88621,431 shs$179.24 million07/17/2025$3.98$3.93-1.26%$4.39$3.651.06 million shs$168.52 million07/16/2025$4.30$3.98-7.44%$4.40$3.95230,443 shs$170.67 million07/15/2025$4.01$4.30+7.23%$4.42$4.00287,322 shs$184.38 million07/14/2025$3.63$4.01+10.47%$4.13$3.60323,707 shs$171.95 million07/11/2025$3.67$3.63-1.09%$3.70$3.5882,747 shs$155.65 million Related Companies Stoke Therapeutics Stock Price Chart Vir Biotechnology Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Day One Biopharmaceuticals Stock Price Chart Dianthus Therapeutics Stock Price Chart KalVista Pharmaceuticals Stock Price Chart Maze Therapeutics Stock Price Chart ArriVent BioPharma Stock Price Chart Mind Medicine (MindMed) Stock Price Chart Arbutus Biopharma Stock Price Chart Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAC) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access